![]() EPD successfully continued with its double-digit sales growth momentum for the last two years. However, Organic sales growth excluding COVID testing increased 10%, led by double-digit growth in Medical Devices, EPD and Nutrition. Total sales in the first quarter were negatively impacted by a year-over-year decline in COVID testing-related sales. The company’s figures declined on a year-over-year basis. (You can read the full research report on Bank of America here >)Ībbott Laboratories shares have declined -8.5% over the past year against the Zacks Medical - Products industry’s decline of -28.8%. The opening of new financial centers and improving digital capabilities will bolster the top line. According to the Zacks analyst estimates NII reflect a CAGR of 2.6% by 2025. Nevertheless, Higher rates and decent loan demand will aid net interest income (NII). Our estimate for total non-interest expenses implies a rise of 1.7% this year. Inflationary pressure will result in mounting expenses. This, along with the volatile nature of the capital markets, will hurt non-interest income.Ī tough operating backdrop will lead to higher provisions, with we projecting a substantial jump in the metric this year. The company is suffering due to worsening economic backdrop which keep weighing on investment banking (IB) business. (You can read the full research report on Procter & Gamble here >)īank of America shares have underperformed the Zacks Banks - Major Regional industry over the past six months (-7.7% vs. Consequently, it raised the sales view to 1% growth compared with our estimate of a 1.1% rise for fiscal 2023. It has been focused on productivity and cost-saving plans to boost margins. Procter & Gamble ’s organic sales grew in the last reported quarter, driven by robust pricing and a favorable mix, along with strength across segments. Driving the underperformance is the company's drab guidance in the last quarterly release and expectations of continued margin pressures. 2.4%) as well as the broader market (-3.6% vs. Procter & Gamble shares have modestly lagged the Zacks Consumer Staples sector (-3.6% vs. You can see all of today’s research reports here > These research reports have been hand-picked from the roughly 70 reports published by our analyst team today. Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Bank of America Corporation (BAC) and Abbott Laboratories (ABT). The Zacks Research Daily presents the best research output of our analyst team.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |